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1. Introduction
  Normal epithelial cells have a typical “apical-basal polarity”, 
wherein, tight and adherent junctions exist between cells. The 
basal surface is connected to the basement membrane. Epithelial 
cells lose the typical epithelium structure and acquire the capacity 
to move around and invade, then become mesenchymal like cells. 
This process is called epithelial-mesenchymal transition(EMT)[1]. 
During the process of EMT transdifferentiation, the expressions of 
characteristic proteins of cells are changed a lot. The expression of 
characteristic proteins of epithelial cells (E-cadherin) is decreased, 
however, the expression of characteristic proteins of mesenchymanl-
like cells (Vimentin, 毩-smooth muscle actin) is increased[2,3]. EMT 
process is completed when epithelial cell basal surface degrades 
and cells migrate away from epithelial layer. As the processing 
of profound studies on tumor, it was found that the growth and 
differentiation of malignant tumors are closely related to stem 
cells, and tumors originated in the stem cells were furthermore 
presumed, the proposal of cancer stem cell concept (CSC) was also 
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put forward[1,4]. Whereafter, tumor stem cells have been isolated 
from acute myeloid leukemia, breast cancers and brain tumors (such 
as astrocytic tumors)[5,6]. Therefore, this study studied on the heat 
shock protein (HSP) HSP90 and SIR3, both induced epithelial cell 
mesenchymal transdifferentiation and enhanced tumor stem cell 
characteristics, so as to promote the occurrence and development 
of liver cancer, and provide a theoretical reference value for the 
subsequent treatment of liver cancer.
2. Materials and methods 
2.1. Cell culture
  Cell line SMMC-7721, HepG2, LO2 and Hep3b were purchased 
from American Type Culture Collection (ATCC). Cells were placed 
in DMEM containing 10% fetal bovine serum, penicillin (100 U/
mL) and streptomycin  (100 毺g/mL),then cultured in the 5% CO2 
incubator at constant temperature 37 曟. Packaging cell line GP2-
293 and retroviral vector pBABE-puro were a gift from Professor 
Mouri Ran of the University of California, Berkeley.
2.2. Detection of HSP90 expression in different liver cancer 
cell lines by RT-PCR
  Total RNA were extracted according to trizol (Invitrogen) kit 
instructions, the whole extracting process was RNAase free. 
Primers were designed as follows, HSP90 gene upstream primer 
sequence: 5’-GGGGGATCCCcagctatgaactccttctcc-3’; downstream 
primer sequence: 5’-GGGGTCGACctacatttgccgaagagccct-3’. 
Glycera ldehyde-3-phosphate  dehydrogenase  (GAPDH) 
as an internal reference, upstream primer sequence: 5’-
TGACTTCAACAGCGACACCCA-3’; downstream primer 
sequence: 5’-CACCCTGTTGCTGTAGCCAAA-3’. cDNA was 
synthesized by reverse transcription with RT-PCR one step method 
kit and amplified by PCR, 5 毺L amplified products were performed 
2% agarose gel eletrophoresis. Electrophoretic bands were measured 
with ultraviolet spectrophotometer and photographed.
2.3. Construction of target gene HSP90 over expression cell 
line
  Human HSP90-HA cDNA was cloned into pBABE-puro expression 
vector. Construction of stabilized expressed cell lines was completed 
by retroviral vector infection method. When packaging cell line 
GP2-293 grew to 60 percent, the lipidosome infection protocol 
(lipidosome 2000, Invitrogen, USA) was used to transfect 5 毺g 
of pBABE-puro or pBABE-puro-HSP90-HA and 5 毺g of pCMV-
VSVG. After transfection for 48 hours, the virus supernatant was 
collected and centrifuged at 3 000 g for 3 minutes. The supernatant 
was transferred to a new clean eppendorf tube and filtered through 
a 0.45 毺m filtrate membrane to obtain experimental viral particles. 
Supernatant was used to infect target cells for 24 h, then placed into 
selective medium containing 2 mg/mL puromycin. HSP90-HA cell 
lines or empty vector cell lines were verified by RT-PCR in vivo 
experiment and Western blot.
2.4.Target gene HSP90-RNAi lentiviral packaging
  Optimal interference sequence designed by Ambion’s software 
which based on target gene was adopted. HSP90 (siRNA 
target sequence of HSP90 is TGATGTAAGTTCTGAGTGTG 
AGCAGTGGAAGCTATTCAGAA) and control (siRNA sequences 
is TGACATGATAATACTCTCT, without interference suppression 
on the expression of human gene). Target fragment was annealed 
by 3 ‘and 5’ single strand and digested by Agel and EcoR栺 (New 
England Biolabs, NEB) restriction enzymes, then it was connected to 
the pGCSIL-GFP vector. After sequencing identification, pGCSIL-
GFP-HSP90 and pGCSIL-GFP-vector was used to transfect Gp2-293 
packaging cells by liposomes 2000. The supernatant was collected 
after 48 h and filtered through a 0.45 毺m filtrate membrane, then 
Polybrene was add into it until the final concentration was 8 毺g/
mL. Supernatant was used to infect target cells for 24 h, then placed 
into new medium for another 24 h. After 48 h infection, cells were 
collected by centrifugation and resuspended in medium containing 
0.5 毺g/mL puromycin. The infected cells were isolated by the 
limiting dilution method. After cells were cultured for 2 weeks, 
resistant monocolonies were selected for amplification culture, and 
HSP90 protein expression was detected by western.
2.5. Detection of EMT-related gene mRNA levels by real-
time quantitative PCR
  Total RNA were extracted according to trizol (Invitrogen) kit 
instructions, the whole extracting process is RNAase free. EMT 
markers associated genes including E-cadherin and vimentin 
mRNAs levels were amplified by real-time quantitative RT-PCR 
with SYBR Green method. GAPDH was taken as an internal 
reference, and then normalization processing was performed for 
data. Three biological checks was conducted in each sample. 
Primer sequences were as follows: E-cadherin, forward primer: 
5’-TGCCCAGAAAATGAAAAAGG-3’, reverse primer 5’-
GTGTATGTGGCAATGCGTTC-3’; vimentin, forward primer: 
5’-GAGAACTTTGCCGTTGAAGC-3’, reverse primer: 5’-
GCTTCCTGTAGGTGGCAATC-3’ and so on.
2.6. Western blot detection
  Western blot method was described as shown in the literature[7]: 
After cell lysis, cell lysis solution was obtained and SDS-PAGE gel 
electrophoresis was conducted. Immunohistochemical analysis was 
performed with anti-E-cadherin and vimentin for further experimental 
analysis to determine the expression levels of each gene in different 
cell samples.
2.7. Tumor cell stemness by flow cytometry
  CD44+/CD24 cell subsets separation were detected by fluorescein 
isothiocyanate-labeled CD44 antibody (BD Biosciences) and PE-
labeled CD24 antibody (BD Biosciences). After cells were labeled, 
Ming Gao et al./Asian Pacific Journal of Tropical Medicine (2015)305-308 307
FACSCalibur flow cytometer (BD Biosciences) was used to detect 
the CD44/CD24 marker. The number of CD44+/CD24- cell subsets 
of hepatocellular carcinoma cell lines was analyzed further.
3. Results 
3.1. HSP90 gene expression of four strains of hepatoma cell 
lines
  Real-time quantitative PCR showed that HSP90 expression in 
smmc-7721 strain was the highest, whereas HSP90 expression in 
Hep3B and LO2 were lower, in which HSP90 expression in HepG2 
were under medium level and more consistent with further study.
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Figure 1. Expressions of HSP90 in HepG2.
3.2. HSP90 overexpression and shRNA lentiviral packaging 
result identification
  As shown in Figure 2, HSP expression was determined by real-
time quantitative PCR and Western blot. Compared with the 
control group, HSP expression in the HSP90 overexpression 
group was significantly increased, whereas HSP expression in the 
HSP90 shRNA group was significantly reduced, which indicated 
the overexpression group and shRNA group were successfully 
established.
 3.3. EMT associated markers protein detection
  The results showed that cells EMT transformation was promoted 
after HSP transfection. E-cadherin protein expression was down-
regulated, whereas vimentin was expression up-regulated. 
Meanwhile in SH-HSP group, due to the interference of HSP 
expression in cells, E-cadherin protein was upregulated, whereas 
vimentin expression was down-regulated (Figure 3). 
3.4. Cancer stem cells percentage by flow cytometry
  The number of apoptosis cells in HSP-siRNA-treated group was 
significantly increased, with the ratio reached 20.52%, whereas 
the ratio of apoptosis in the control group was 5%. Meanwhile, the 
apoptosis rate in HSP overexpression group was reduced to 5.6%, 
which was significantly decreased when compared with the control 
group, suggesting that the expression of HSP can suppress the 
apoptosis of tumor cells.
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Figure 2. HSP90 overexpression and shRNA lentiviral packaging result 
identification.
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Figure 3. EMT associated markers protein detection.
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Figure 4. Cancer stem cells percentage by flow cytometry.
4. Discussion 
  HSP is induced by various stressor such as high temperature, 
anoxia, heavy metal poisoning, infection, starvation, trauma, 
metabolic poisons and so on, the HSP gene was activated and there 
are a group of highly expressed and highly conserved proteins. 
HSP widely exists in people, animals, microorganisms and plant 
cells[8]. As a molecular chaperone, the main function of HSP is to 
participate in the processes of protein folding, subunits composition, 
intracellular transport and protein degradation, to regulate the 
activity and function of the target protein, but it is not involved in the 
composition of HSP target protein[9].
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  HSP90 is one of the most important proteins of heat shock protein 
family. As a molecular chaperone, HSP90 is involved in regulating 
and maintaining the conformation and function of a variety of 
proteins within cells. It plays an important role in regulating cell 
growth, differentiation and apoptosis, etc[10]. It can be combined 
with a variety of signaling proteins and stabilize their activity, and 
thus participate in the regulation of important activity of cellular 
processes[11]. Currently there are more than 100 kinds of HSP90 
substrate proteins[12], accumulating evidences showed that many of 
HSP90 is closely related to tumor invasion and metastasis. Studies 
have shown that HSP90 inhibition can inhibit HGF / SFMET 
signaling pathway, decline the invasive ability and migration 
ability[13]. Recent studies have shown that after the inhibition of 
HSP90, the invasion and metastasis of EGF-induced thyroid cancer 
can be inhibited[14].
  SIRT3 is an extracellular matrix protein, which is highly expressed 
in many malignant tumors, and is closely related to tumor invasion 
and metastasis. SIRT3 has been reported to promote tumor stem 
cells stemness and inhibit the differentiation of adipose-derived 
stem cells, but the relationship between promoting metastasis and 
the characteristics of mesenchymal stem cell as the pluripotent stem 
cell is still not clear[15]. We found that SIRT3 can give stem cell 
characteristics to human hepatocellular carcinoma epithelial cells 
and liver cancer cells, and has a mesenchymal-like characteristics. At 
the same time, SIRT3 is highly expressed in bone marrow-derived 
and its differentiated adipocytes, osteoblasts and chondrocytes. After 
the over-expression of SIRT3 protein or rescheduled SIRT3 protein, 
the human hepatocellular carcinoma epithelial cells and liver cancer 
cells can differentiate to multiple directions like MSCs. 
  In animal experiments, human hepatocellular carcinoma epithelial 
cells with SIRT3 overexpression can promote the tumor formation 
and pulmonary metastasis of human hepatocellular carcinomas 
cancer cells in mice[16]. Therefore, SIRT3 protein can promote 
human hepatocellular carcinoma epithelial cells and liver cancer 
cells to obtain the potential of differentiate to multiple directions 
of some mesenchymal stem cells, and promote tumor growth and 
metastasis.
  Therefore, this study discusses the development of liver cancer 
from the heat shock protein HSP90 and SIR3’s synergistic effect 
on inducing epithelial cell mesenchymal transdifferentiation and 
enhancing characteristics of cancer stem cells. We detected HSP90 
and SIR3 expressions in different liver cancer cell lines by modern 
molecular biology techniques such as real-time quantitative PCR 
and Western blot method, and further use the genes up-regulated 
and down-regulated technology to study the role of HSP90 in the 
development and progression of HCC EMT. The results showed 
that HSP90 can be used as an indicator to determine the biological 
behavior of malignant liver cancer and predict the risk of metastasis. 
Therefore, inhibited HSP90 expression and activity can provide new 
approach for blocking liver cancer cell metastasis in clinical and 
provide new method in anti-tumor invasion and metastasis.
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